Related Experiment Video
Updated: Aug 12, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Overwhelming consumption in prisons: human rights and tuberculosis control
Tuberculosis is the leading cause of death in prisons globally. Adapting HIV control guidelines offers a new human rights approach to combat tuberculosis (TB) in correctional facilities.
Area of Science:
- Public Health
- Human Rights Law
- Infectious Disease Control
Background:
- Tuberculosis (TB) is the primary cause of mortality among incarcerated populations worldwide.
- Current TB control strategies in prisons are insufficient, lacking a human rights framework.
- There is a critical need for innovative approaches to address the TB epidemic in correctional settings.
Purpose of the Study:
- To propose the adaptation of existing Human Immunodeficiency Virus (HIV) control guidelines for tuberculosis (TB) management in prisons.
- To advocate for the application of a human rights-based approach to TB control within correctional facilities.
- To establish prisons as a platform for developing and testing novel TB control concepts.
Main Methods:
- Review and adaptation of established HIV control guidelines.
- Conceptual framework development integrating human rights principles.
- Application of adapted guidelines within the prison context.
Main Results:
- Identification of key components from HIV guidelines applicable to TB control.
- Development of a human rights-centered strategy for prison TB programs.
- Establishment of a model for TB control in correctional settings.
Conclusions:
- Adapting HIV guidelines provides a viable human rights-based strategy for prison TB control.
- Prisons can serve as a crucial setting for implementing and refining public health interventions.
- A human rights approach is essential for effective tuberculosis elimination in vulnerable populations.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
10:24Identification of Potential Anti-TB Candidates: A Step-by-Step Guide to Synthesis, MIC Determination, and Cytotoxicity Assessment in Mammalian Cells
Published on: May 22, 2026
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis